JPMORGAN CHASE & CO - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$1,942
-35.3%
10,219
+32.0%
0.00%
Q1 2023$3,000
+99900.0%
7,744
-17.2%
0.00%
Q4 2022$3
-99.9%
9,355
-3.0%
0.00%
Q3 2022$4,0000.0%9,644
+4.1%
0.00%
Q2 2022$4,000
-71.4%
9,261
-19.1%
0.00%
Q1 2022$14,000
-6.7%
11,449
-5.2%
0.00%
Q4 2021$15,000
-40.0%
12,081
-0.8%
0.00%
Q3 2021$25,000
-56.9%
12,180
-67.1%
0.00%
Q2 2021$58,000
-79.0%
37,012
-70.2%
0.00%
Q1 2021$276,000
-13.2%
124,341
-3.3%
0.00%
Q4 2020$318,000
+191.7%
128,604
+209.5%
0.00%
Q3 2020$109,000
-28.8%
41,547
-3.3%
0.00%
Q2 2020$153,000
+264.3%
42,984
+127.1%
0.00%
Q4 2019$42,000
+13.5%
18,930
-4.6%
0.00%
Q3 2019$37,000
+23.3%
19,837
+3.4%
0.00%
Q2 2019$30,000
-43.4%
19,191
-28.7%
0.00%
Q1 2019$53,000
+55.9%
26,913
+4.3%
0.00%
Q4 2018$34,000
+88.9%
25,815
+244.2%
0.00%
Q3 2018$18,000
-43.8%
7,500
-21.7%
0.00%
Q2 2018$32,000
-20.0%
9,575
+2.3%
0.00%
Q1 2018$40,000
+60.0%
9,357
+23.2%
0.00%
Q4 2017$25,0007,5960.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders